Abstract
Background and purpose
Mechanical thrombectomy (MT) improves early clinical outcome in patients with acute ischemic stroke but insights on determinants of long-term outcome after MT treatment are scarce.
Methods
Data from stroke patients with anterior circulation large vessel occlusion of a prospective MT registry (01/2014–06/2017) of a large comprehensive stroke center were analyzed regarding clinical outcome between short- (3 months) and long-term (12 months) assessment reflected by a change of modified Rankin scores (∆mRS). Secondary endpoints included favorable long-term outcome (mRS 0–2). Multi-variable regression analysis was performed to identify determinants of outcome changes and favorable outcome at long term.
Results
Of 264 patients included, 42.0% showed a favorable long-term outcome. Longitudinal analysis found that some individuals still improved, but no overall mRS difference between short and long-term follow-up was detected [∆mRS − 0.004 (95% CI − 0.020; 0.013); p = 0.672]. Right hemispheric stroke [∆mRS 0.286 (0.011; 0.561); p = 0.043] and high NIHSS at discharge [∆mRS, 0.039 (0.004; 0.074); p = 0.029] were associated with a longitudinal mRS decline. Favorable long-term outcome was associated with successful recanalization (p < 0.0001).
Conclusions
A significant number of patients with MT experience a favorable long-term outcome. Outcomes remained stable between short- and long-term follow-up, but some individuals may still show improvement beyond short-term rehabilitation. Right hemispheric stroke and clinical stroke severity at hospital discharge may be frail predictors for delayed decline of functional status, whereas successful recanalization remains a positive outcome predictor. Death rarely occurs beyond 3 months after MT treatment.
Similar content being viewed by others
References
Goyal M, Menon BK, Van Zwam WH, Dippel DWJ, Mitchell PJ, Demchuk AM et al (2016) Endovascular thrombectomy after large-vessel ischaemic stroke: A meta-analysis of individual patient data from five randomised trials. Lancet 387(10029):1723–1731. https://doi.org/10.1016/S0140-6736(16)00163-X
van den Berg LA, Dijkgraaf MGW, Berkhemer OA, Fransen PSS, Beumer D, Lingsma HF et al (2017) Two-year outcome after endovascular treatment for acute ischemic stroke. N Engl J Med 376(14):1341–1349. https://doi.org/10.1056/NEJMc1705673
Dávalos A, Cobo E, Molina CA, Chamorro A, de Miquel MA, Román LS et al (2017) Safety and efficacy of thrombectomy in acute ischaemic stroke (REVASCAT): 1-year follow-up of a randomised open-label trial. Lancet Neurol 16(5):369–376. https://doi.org/10.1016/S1474-4422(17)30047-9
Powers W, Rabinstein A, Ackerson T, Adeoye O, Bambakidis N, Becker K et al (2018) Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 49(3):46–110. https://doi.org/10.1161/STR.0000000000000158
Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL et al (1993) Classification of subtype of acute ischemic stroke definitions for use in a multicenter clinical trial. Stroke 24(1):35–41
Saver JL, Filip B, Hamilton S, Yanes A, Craig S, Cho M et al (2010) Improving the reliability of stroke disability grading in clinical trials and clinical practice: the Rankin Focused Assessment (RFA). Stroke 41(5):992–995. https://doi.org/10.1161/STROKEAHA.109.571364
Yoo AJ, Berkhemer OA, Fransen PSS, van den Berg LA, Beumer D, Lingsma HF et al (2016) Effect of baseline Alberta Stroke Program Early CT Score on safety and efficacy of intra-arterial treatment: a subgroup analysis of a randomised phase 3 trial (MR CLEAN). Lancet Neurol 15(7):685–694. https://doi.org/10.1016/S1474-4422(16)00124-1
Von KR, Broderick JP, Campbell BCV, Demchuk A, Goyal M, Hill MD et al (2015) The Heidelberg bleeding classification classification of bleeding events after ischemic stroke and reperfusion therapy. Stroke 46(10):2981–2986. https://doi.org/10.1161/STROKEAHA.115.010049
Zaidat OO, Yoo AJ, Khatri P, Tomsick TA, von Kummer R, Saver JL et al (2013) Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke 44(9):2650–2663. https://doi.org/10.1161/STROKEAHA.113.001972
Royston P, Moons K, Altman D, Vergouwe Y (2009) Prognosis and prognostic research: developing a prognostic model. BMJ Br Med J 31(1):604. https://doi.org/10.1136/bmj.b604
Sauerbrei W, Royston P, Binder H (2007) Selection of important variables and determination of functional form for continuous predictors in multivariable model building. Stat Med 26(30):5512–5528
Sauerbrei W (1999) The use of resampling methods to simplify regression models in medical statistics. J R Stat Soc Ser C (Appl Stat) 48(3):313–329
Wallesch CW (2015) Integrierte Versorgung bei Schlaganfall. Bundesgesundheitsblatt Gesundheitsforsch Gesundheitsschutz 58(4–5):393–397
Bundesarbeitsgemeinschaft für Rehabilitation (1999) Empfehlungen zur Neurologischen Rehabilitation von Patienten mit schweren und schwersten Hirnschädigungen in den Phasen B und C. In Frankfurt, pp 1–47. https://www.bar-frankfurt.de/service/publikationen/produktdetails/produkt/35.html
Di LS, Saposnik G, Nilanont Y, Hachinski V, Legge D (2006) Neglecting the difference does right or left matter in stroke outcome after thrombolysis ? Stroke 37:2066–2069
Rastogi V, Lamb DG, Williamson JB, Stead TS, Penumudi R, Bidari S et al (2015) Hemispheric differences in malignant middle cerebral artery stroke. J Neurol Sci 353:20–27. https://doi.org/10.1016/j.jns.2015.04.036
Fink JN, Frampton CM, Lyden P, Lees KR, Investigators on behalf of the V (2008) Does hemispheric lateralization influence functional and cardiovascular outcomes after stroke ? An analysis of placebo-treated patients from prospective acute stroke trials. Stroke 39:3335–3340. https://doi.org/10.1161/STROKEAHA.108.523365
Jehkonen M, Laihosalo M, Kettunen J (2006) Impact of neglect on functional outcome after stroke: a review of methodological issues and recent findings. Restor Neurol Neurosci 24(4–6):209–215
Naess H, Waje-andreassen U, Thomassen L (2006) High incidence of infarction in the left cerebral hemisphere among young adults. J Stroke Cerebrovas Dis 15(6):241–244
Foerch C, Misselwitz B, Sitzer M, Berger K, Steinmetz H, Neumann-Haefelin T et al (2005) Research letters difference in recognition of right and left hemispheric stroke. Lancet 366:392–393
Yoshimura S, Lindley RI, Carcel C, Sato S (2018) NIHSS cutoff point for predicting outcome in supra- vs infratentorial acute ischemic stroke. Neurol Sci 91:e1695–e1701. https://doi.org/10.1212/WNL.0000000000006437
Wu Z, Zeng M, Li C, Qiu H, Feng H, Xu X et al (2019) Time-dependence of NIHSS in predicting functional outcome of patients with acute ischemic stroke treated with intravenous thrombolysis. Postgr Med J 95:181–186. https://doi.org/10.1136/postgradmedj-2019-136398
Gilgen MD, Klimek D, Liesirova KT, Meisterernst J, Klinger-Gratz PP, Schroth G et al (2015) Younger stroke patients with large pretreatment diffusion-weighted imaging lesions may benefit from endovascular treatment. Stroke 46(9):2510–2516. https://doi.org/10.1161/STROKEAHA.115.010250
Daniere F, Lobotesis K, Machi P, Eker O, Mourand I, Riquelme C et al (2015) Patient selection for stroke endovascular therapy—DWI-ASPECTS thresholds should vary among age groups: insights from the RECOST Study. AJNR Am J Neuroradiol 36:32–39. https://doi.org/10.3174/ajnr.A4104
Saver JL, Goyal M, Van Der Lugt A, Menon BK, Majoie CBLM, Dippel DW et al (2016) Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. JAMA J Am Med Assoc 316(12):1279–1288. https://doi.org/10.1001/jama.2016.13647
Ismail M, Armoiry X, Tau N, Zhu F, Sadeh-Gonik U, Piotin M et al (2019) Mothership versus drip and ship for thrombectomy in patients who had an acute stroke: a systematic review and meta-analysis. J Neurointerv Surg 11(1):14–19. https://doi.org/10.1136/neurintsurg-2018-014249
Arboix A, Cartanya A, Lowak M, Garcia-Eroles L, Parra O, Oliveres M et al (2014) Gender differences and woman-specific trends in acute stroke: results from a hospital-based registry (1986–2009). Clin Neurol Neurosurg 127:19–24. https://doi.org/10.1016/j.clineuro.2014.09.024
Chalos V, De Ridder I, Lingsma H, Brown S, van Oostenbrugge R, Goyal M et al (2019) Does sex modify the effect of endovascular treatment for ischemic stroke? Stroke 50(9):2413–2419. https://doi.org/10.1161/STROKEAHA.118.023743
Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, San Román L, Serena J, Abilleira S, Ribó M, Millán M, Urra X, Cardona P, López-Cancio E, Tomasello A, Castaño C, Blasco J, Aja L, Dorado L, Quesada H, Rubiera M, Hernandez-Pérez M, Goyal M, DA. (2015) Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 372(24):2296–2306. https://doi.org/10.1056/NEJMoa1503780
Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM et al (2015) SolitaireTM with the intention for thrombectomy as primary endovascular treatment for acute ischemic stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV t. Int J Stroke 10(3):439–448. https://doi.org/10.1111/ijs.12459
Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, Roy D, Jovin TG, Willinsky RA, Sapkota BL, Dowlatshahi D, Frei DF, Kamal NR, Montanera WJ, Poppe AY, Ryckborst KJ, Silver FL, Shuaib A, Tampieri D, Williams D, Bang OY, Baxter BW, Burns PA, Cho HM (2015) Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 372(11):1019–1030. https://doi.org/10.1056/NEJMoa1414905
Blanco-Rojas L, Arboix A, Canovas D, Grau-Olivares M, Oliva Morera J, Parra O (2013) Cognitive profile in patients with a first-ever lacunar infarct with and without silent lacunes: a comparative study. BMC Neurol 13:203. https://doi.org/10.1186/1471-2377-13-203
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
Dr. Fuhrer has nothing to disclose. Dr. Forner has nothing to disclose. Mr. Pruellage has nothing to disclose. Dr. Schacht has nothing to disclose. Ms. Weber has nothing to disclose. Dr. Beume has nothing to disclose. Prof. Bardutzky reports speaking honoraria from Bayer Health Care, Boehringer Ingelheim, Daiichi Sankyo and Pfizerm, outside the submitted work. Prof. Weiller has nothing to disclose. Dr. Egger is shareholder of the VeoBrain GmbH and reports honoraria payments for specific speeches and seminar presentations from Stryker, outside the submitted work. Prof. Urbach is shareholder of the VeoBrain GmbH, outside the submitted work. Dr. Niesen has nothing to disclose. Prof. Meckel reports consultant fees for membership of the scientific advisory board of Acandis; speaker honorarium (modest), travel grant, video case support (non-financial) from Medtronic; travel grants from Microvention; Stryker; research grant (money paid to institution) from Bracco S.p.A; consultant fee from Novartis Pharma GmbH, all outside the submitted work.
Ethical standards
This study was carried out in accordance with the Declaration of Helsinki and the recommendations and approval of the protocol of the ethics committee, Germany (University of Freiburg, EK2/13, date of approval 05/28/2013).
Informed consent
Informed patients’ consent was obtained
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Fuhrer, H., Forner, L., Pruellage, P. et al. Long-term outcome changes after mechanical thrombectomy for anterior circulation acute ischemic stroke. J Neurol 267, 1026–1034 (2020). https://doi.org/10.1007/s00415-019-09670-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-019-09670-w